“Base-Editing and Gene-Silencing Approaches to Lipid Lowering: A One-Off Treatment and a Lifetime of Consent” (2026) Journal of Heart and Cardiovascular Science, 7(1), pp. 37–42. doi:10.5281/zenodo.22642010.